To the best of our knowledge, our study is the first to reveal that STC2 silencing suppresses EMT and glycolysis by inhibiting ITGB2/FAK/SOX6 signaling in NPC. This evidence concerns the gene ITGB2 and nasopharyngeal carcinoma.